Progress Pulse

Hearing is a gateway to learning for young children treated for cancer

Heather Conklin

Heather Conklin, PhD, St. Jude Division of Neuropsychology chief and St. Jude Department of Psychology and Biobehavioral Sciences member works to understand how to protect childhood cancer survivors’ hearing and neurocognitive health.

Young children treated for brain tumors experience specific treatment-related effects from therapy, including hearing loss. A study led by Heather Conklin, PhD, St. Jude Department of Psychology and Biobehavioral Sciences found that young children (those less than 3 years old) that experience hearing loss also show lower IQs, attention spans and adaptive functioning skills, with the youngest being the most impacted. The results indicate a need for early and frequent hearing assessments and educational interventions in this population to potentially mitigate the effect. The findings were published in Neuro-Oncology

“Given that hearing loss is potentially avoidable with adjustments to cancer treatment and that there are methods to aid hearing and support learning in children who experience hearing loss, these findings offer opportunities to improve cognitive and academic outcomes for our youngest survivors,” said Conklin.

Read more

Recent Progress Pulse Stories

Sequencing large-scale changes in DNA to detect cancer earlier

Expedited and accurate detection of targeted gene fusions with St. Jude Fuzzion2

Reducing the risk of cerebellar mutism syndrome through surgical guidelines

Global collaboration reduces preventable infections during pediatric cancer treatment

Stay ahead of the curve